ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Pass Above 50-Day Moving Average – Should You Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $21.37 and traded as high as $22.47. ChronoScale Corporation Common Stock shares last traded at $19.39, with a volume of 361,135 shares trading hands.

ChronoScale Corporation Common Stock Stock Up 7.9%

The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.03 and a current ratio of 1.55. The company has a fifty day simple moving average of $21.37 and a two-hundred day simple moving average of $15.01. The firm has a market capitalization of $74.01 million, a PE ratio of -3.86 and a beta of 1.00.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings data on Tuesday, June 30th. The company reported ($3.89) earnings per share (EPS) for the quarter. The business had revenue of $18.09 million for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Analysts forecast that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. J.Safra Asset Management Corp acquired a new position in shares of ChronoScale Corporation Common Stock during the second quarter worth $105,000. Roble Belko & Company Inc raised its holdings in shares of ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after purchasing an additional 1,195 shares during the last quarter. Great Lakes Advisors LLC acquired a new stake in ChronoScale Corporation Common Stock during the 2nd quarter worth about $755,000. TrinityBridge Ltd acquired a new stake in ChronoScale Corporation Common Stock during the second quarter worth about $737,000. Finally, Virtu Financial LLC acquired a new position in ChronoScale Corporation Common Stock in the third quarter valued at approximately $57,000. Hedge funds and other institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.